Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance
Roger Greenwood(Mount Sinai Beth Israel), Nathan W. Levin(Renal Research Institute), Mary Carter(University of Exeter), Alessandra Brendolan, Lenore Bruno(Lister Hospital), Claudio Ronco(Ospedale San Bortolo), Len A. Usvyat, Peter Homel, Fiorella Gastaldon
Cited by 26
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k